ECO Animal Health Group plc (AIM:EAH)
London
· Delayed Price · Currency is GBP · Price in GBX | Market Cap | 63.69M |
| Revenue (ttm) | 85.81M |
| Net Income (ttm) | 3.02M |
| Shares Out | 67.76M |
| EPS (ttm) | 0.04 |
| PE Ratio | 21.65 |
| Forward PE | 31.54 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 69,972 |
| Average Volume | 110,098 |
| Open | 95.00 |
| Previous Close | 94.00 |
| Day's Range | 90.00 - 95.00 |
| 52-Week Range | 55.56 - 116.90 |
| Beta | 0.05 |
| RSI | 45.46 |
| Earnings Date | Jul 10, 2026 |
About ECO Animal Health Group
ECO Animal Health Group plc, together with its subsidiaries, manufactured and supply animal health products internationally. The company provides Aivlosin, a macrolide antibiotic for the treatment of enteric and respiratory diseases in pigs and poultry. It also offers generic drugs, such as Ecomectin, Ecoheart, Ecotraz, and Ecomintic, which are endectocides and other antiparasitics for the treatment and prevention of parasites in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infectio... [Read more]
Financial Performance
In fiscal year 2025, ECO Animal Health Group's revenue was 79.60 million, a decrease of -10.99% compared to the previous year's 89.42 million. Earnings were 1.69 million, an increase of 60.88%.
Financial StatementsNews
ECO Animal Health Announces EU Marketing Authorisation For ECOVAXXIN MS
(RTTNews) - ECO Animal Health Group plc (EAH.L) announced that the European Commission has adopted a decision granting EU marketing authorisation for ECOVAXXIN MS, the company's poultry vaccine agains...
ECO Animal Health Receives Positive Opinion From CVMP For ECOVAXXIN MS
(RTTNews) - ECO Animal Health Group plc announced that the Committee for Medicinal Products for Veterinary Use of the European Medicines Agency has adopted a Positive Opinion recommending the granting...
AIM Market Roundup: Oxford Biodynamics, GCM Resources, ECO Animal Health
Oxford Biodynamics, GCM, ECO Animal Health are today's top risers, while Cirata, Caledonian Holdings take the biggest fall on London's AIM